Skip to content

ASDDefiance Autism Impact ETF

Grow my moneyNewRanked #2,878 of 2,978 in this goal

Tracks the total return performance of the VettaFi Autism Impact Index.

By Defiance ETFs LLC · Launched 2026

Annual Cost

0.79%

#4,143 of 5,756 · expensive

Fund Size

$1M

#5,550 of 5,756 · small

Return (1Y)Goal

N/A

Track Record

1 month

#5,567 of 5,756 · young

Performance

Total-return NAV · USD
Growth of $10,000
$11,233+12.3%

Total-return NAV, USD. Net of fund fees, before tax.

What's inside

How Beacon categorizes this fund

Asset class

Equity

Region

Global

Strategy

Index tracking

Index tracked

VettaFi Autism Impact Index

What it actually holds

By weight

Concentration

Top 10 holdings = 30.8% of fundwell diversified

Definium Therapeutics Inc Ordinary SharesDFTX
4.8%
Neuren Pharmaceuticals LtdNEU.AX
3.2%
LifeStance Health Group Inc Ordinary SharesLFST
3.0%
Otsuka Holdings Co Ltd4578.T
3.0%
Acadia Healthcare Co IncACHC
2.9%
ACADIA Pharmaceuticals IncACAD
2.9%
MapLight Therapeutics IncMPLT
2.9%
AbbVie IncABBV
2.7%
BrightSpring Health Services IncBTSG
2.7%
Revvity IncRVTY
2.7%

Asset allocation

Stocks
99.8%
Cash
0.2%

By sector

Healthcare
88.0%
Consumer Defensive
4.4%
Consumer Cyclical
2.7%
Communication
2.6%
Industrials
2.4%

Risk profile

Last 12 months · Sharpe & Sortino need 3+ years
Volatility (1Y)
N/A
Max drawdown
-2.9%Mild

Worst peak-to-trough loss

Sharpe (3Y)
Unavailable

Needs 3+ years of history

Sortino (3Y)
Not yet

Needs 3+ years of history

Listing

Exchange
NASDAQ Global Select Market

Full fund details

Objective
Tracks the total return performance of the VettaFi Autism Impact Index.
Strategy
Uses a passive management approach to track the total return performance of the VettaFi Autism Impact Index, which measures publicly traded global companies in developed markets that support the autism ecosystem. The Fund invests at least 80% of its net assets in Autism Impact Companies across the Health Care sector.
Inception date
June 1, 2026
Fund family
Defiance ETFs LLC

What's next?

You've looked at ASD. Save it to your watchlist to weigh it against other funds, then turn your shortlist into a portfolio.

Data updated on 2026-07-22